Stericycle (SRCL) Lowered to “Strong Sell” at BidaskClub

Stericycle (NASDAQ:SRCL) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Wednesday.

A number of other research firms have also recently commented on SRCL. BMO Capital Markets decreased their target price on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating on the stock in a research report on Monday, August 6th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Monday, October 1st. Robert W. Baird decreased their target price on shares of Stericycle from $70.00 to $56.00 and set a “neutral” rating on the stock in a research report on Friday, November 2nd. Northcoast Research reissued a “neutral” rating on shares of Stericycle in a research report on Friday, October 12th. Finally, Bank of America began coverage on shares of Stericycle in a research report on Monday, October 22nd. They set an “underperform” rating and a $53.00 price target on the stock. Five investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the stock. Stericycle currently has an average rating of “Hold” and an average target price of $65.38.

NASDAQ SRCL opened at $46.80 on Wednesday. Stericycle has a 12 month low of $45.55 and a 12 month high of $76.73. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market capitalization of $4.06 billion, a price-to-earnings ratio of 10.78, a P/E/G ratio of 1.24 and a beta of 0.52.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, November 1st. The business services provider reported $1.03 EPS for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.02. Stericycle had a net margin of 4.63% and a return on equity of 13.74%. The company had revenue of $854.90 million for the quarter, compared to analysts’ expectations of $856.36 million. During the same quarter in the prior year, the company posted $1.10 earnings per share. Stericycle’s revenue for the quarter was down 3.2% compared to the same quarter last year. As a group, analysts predict that Stericycle will post 4.37 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently modified their holdings of SRCL. Whittier Trust Co. lifted its position in shares of Stericycle by 362.6% during the second quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock worth $129,000 after purchasing an additional 852 shares in the last quarter. Zions Bancorporation acquired a new stake in shares of Stericycle during the third quarter worth about $130,000. Dupont Capital Management Corp lifted its position in shares of Stericycle by 102.2% during the second quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock worth $136,000 after purchasing an additional 1,056 shares in the last quarter. Pflug Koory LLC lifted its position in shares of Stericycle by 106.6% during the third quarter. Pflug Koory LLC now owns 2,810 shares of the business services provider’s stock worth $165,000 after purchasing an additional 1,450 shares in the last quarter. Finally, NumerixS Investment Technologies Inc lifted its position in shares of Stericycle by 285.0% during the second quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock worth $174,000 after purchasing an additional 1,995 shares in the last quarter. 95.11% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Featured Story: Can individual investors take part in an IPO?

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply